Capricor Therapeutics options imply 7.5% move in share price post-earnings
Pre-earnings options volume in Capricor Therapeutics (CAPR) is normal with calls leading puts 19:7. Implied volatility suggests the market is ...
Kalkine Media22h
How Is Capricor Therapeutics (NASDAQ:CAPR) Progressing in Its Clinical Trials?
Highlights,Capricor Therapeutics is a biotechnology company specializing in the development of treatments for rare disorders.